首页> 外文OA文献 >Dynamics of structural, functional and vegetative changes of heart under the influence of combined therapy with the use of ursodeoxycholic acid and L-arginine in patients with coronary heart disease associated with nonalcoholic fatty liver disease
【2h】

Dynamics of structural, functional and vegetative changes of heart under the influence of combined therapy with the use of ursodeoxycholic acid and L-arginine in patients with coronary heart disease associated with nonalcoholic fatty liver disease

机译:核糖胆酸和L-精氨酸患者中冠心病患者核心致胆肝病患者的结构,功能和营养变化的动态,非酒精性脂肪肝病患者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: to study the effect of the ursodeoxycholic acid and L-arginine combination on the background of basic therapy on the structural and functional state of the heart and indicators of the autonomic nervous system in patients with coronary heart disease combined with the non-alcoholic fatty liver disease.Methods: The study involved 56 patients with coronary heart disease (CHD) and nonalcoholic fatty liver disease (NAFLD). Patients were randomized into two groups. Patients in the 1st group (n = 30) received only basic therapy of coronary heart disease, patients in the 2nd group (n = 26) in addition to basic therapy were prescribed with UDCA and L-arginine. All patients underwent daily ECG monitoring and two-dimensional echocardiography. Statistical data processing was carried out using the program package Statistica 10.0.Results: In the 2nd group after 3 months of treatment there were observed decrease in indicators: myocardial stiffness index by 45 %, Va by 7.4 %, mean heart rate in both the active (11.72 %) and the passive (8 %) periods, the number (80 %) and duration (85 %) of tachycardia episodes, total number of ventricular (84 %) and supraventricular (63 %) extrasystoles per day, duration of the ST depression (by 55 %) and the duration of its maximum episode (by 75 %) and LF/HF ratio to 24 % in the active and 27 % in the passive period along with an increase of indicators: Ve by 7.4 %, SDNNi in both active (18 %) and passive (20 %) periods (p < 0.05).Conclusions: The positive effects of adding UDCA and L-arginine to basic therapy in patients with coronary artery disease and NAFLD include improved diastolic function, decreased myocardial ischemia, decreased myocardial stiffness and the number of ventricular and supraventricular extrasystoles, as well as increased total VPS, normalization of the sympathetic-parasympathetic balance by increasing the parasympathetic component of the cardiovascular system.
机译:目的:探讨核糖烷酸和L-精氨酸组合对冠心病患者心脏病患者心脏和指标的基础治疗背景下的影响,冠心病与非酒精性脂肪组合的患者肝病。方法:该研究涉及56例冠心病(CHD)和非酒精性脂肪肝病(NAFLD)。患者被随机分为两组。患者在第1组(n = 30)中仅接受冠心病的基本治疗,第2组(n = 26)除了基础疗法外,用UDCA和L-精氨酸规定。所有患者都经过每日ECG监测和二维超声心动图。使用程序包统计部10.0执行统计数据处理。结果:在第2组治疗后,观察到指标的降低:心肌刚度指数下降45%,VA在活性(11.72%)和被动(8%)期间的平均心率,心动过速发作的数量(80%)和持续时间(85%),心室(84%)和髁间额外(63%)每天溢囊,ST抑郁症(55%)和其最大持续时间第(75%)和LF / HF比率在活跃期内的24%和27%,随着指标的增加:VE达到7.4%,SDNNI在活性(18%)和被动(20%)期间(P <0.05)。结论:将UDCA和L-精氨酸添加到冠状动脉疾病和NAFLD患者基础疗法的积极影响包括改善的舒张功能,降低心肌缺血,降低心肌刚度和心室和室性额外额外的数量,以及增加的总VPS ,通过增加心血管系统的副交感神经组分来正常化同情副交感平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号